✦ LIBER ✦

Evolving options for the treatment of metastatic breast cancer: Progression-free survival as an endpoint

✍ Scribed by Sara A. Hurvitz

Book ID: 116395549
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 207 KB
Volume: 37
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2011.01.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of the metastatic breast cancer prog

Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer

✍ Hurvitz, Sara A.; Lalla, Deepa; Crosby, Ross D.; Mathias, Susan D. 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 187 KB

Health-related quality of life as progno

✍ Helene Svensson, Thomas Hatschek, Hemming Johansson, Zakaria Einbeigi, Yvonne Br 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 180 KB

Tumor response and progression-free surv

Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer : Findings on the basis of North Central Cancer Treatment Group trials

✍ Nathan R. Foster; Yingwei Qi; Qian Shi; James E. Krook; John W. Kugler; James R. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

Re: Validation of Serum Amyloid α as an

Re: Validation of Serum Amyloid α as an Independent Biomarker for Progression-Free and Overall Survival in Metastatic Renal Cell Cancer Patients

✍ Laguna, M. Pilar 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 107 KB

Elevated level of peripheral CD8+CD28−T

Elevated level of peripheral CD8+CD28−T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy

✍ Guohong Song, Xiaoli Wang, Jun Jia, Yanhua Yuan… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 239 KB

125 Baseline bone metabolism markers as

125 Baseline bone metabolism markers as predictors for progression-free survival of patients with treatment-naïve bone-metastatic prostate cancer treated with zoledronic acid plus combined androgen blockade

✍ M. Nozawa; T. Inagaki; K. Nagao; T. Nishioka; T. Komura; A. Esa; M. Kitagawa; M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 19 KB